SCHEMBL27612872

SCHEMBL27612872

Nc1nc(N)c(F)c(-c2ccc(O)cc2)n1

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PIK3CG P48736 5/20 0.56
ADORA2A P29274 4/20 0.49
ADORA1 P30542 4/20 0.49
USP7 Q93009 1/20 0.44
IKBKB O14920 1/20 0.42
CHUK O15111 1/20 0.42
RPS6KA3 P51812 1/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
MAPT P10636 1/20 0.39
BLM P54132 1/20 0.39
LTA4H P09960 1/20 0.38
MKNK1 Q9BUB5 1/20 0.38
MKNK2 Q9HBH9 1/20 0.38
SCN9A Q15858 1/20 0.38
MYC P01106 1/20 0.36
WDR5 P61964 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27612570 0.85 MAPT (0.53) PIK3CGADORA2AADORA1MEN1KMT2A
SCHEMBL27631651 0.85 ADORA2A (0.54) ADORA2AADORA1CHUKMEN1KMT2A
Hydrochloric Acid SCHEMBL28757234 0.83 MAPT (0.51) PIK3CGADORA2AADORA1MEN1KMT2A
SCHEMBL4407006 0.81 NPC1 (0.50) ADORA2AADORA1MEN1KMT2A
SCHEMBL27631713 0.81 ADORA2A (0.51) ADORA2AADORA1RPS6KA3MEN1KMT2A
SCHEMBL27612323 0.81 CSNK1A1 (0.55) PIK3CGADORA2AADORA1SCN9A
SCHEMBL27631860 0.80 POLB (0.49) ADORA2AKMT2AMAPT
SCHEMBL21802136 0.80 PIK3CG (0.47) PIK3CGRPS6KA3
SCHEMBL1116418 0.80 PIK3CG (0.60) PIK3CGADORA2AADORA1IKBKBCHUK
SCHEMBL27716588 0.79 CSNK1A1 (0.53) PIK3CGADORA2AADORA1SCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1678321-A Methods of treating or preventing autoimmune diseases with 2, 4-pyrimidinediamine compounds RIGEL PHARMACEUTICALS INC (US) 2005-10-05 CN disclosed